Join Growin Stock Community!
Back to PFE.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

eps-diluted-chart

PFE EPS Diluted

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25 (2025-12-31), Pfizer's diluted EPS stands at -0.29 USD, reflecting a sharp decline from the previous quarter's 0.62 USD. The year-over-year EPS growth rate for this period is -514.29%, indicating a significant deterioration in earnings performance compared to Q4'24. Over the period from Q1'23 to Q4'25, Pfizer's diluted EPS has exhibited considerable volatility, with notable swings between positive and negative values. After reaching a low of -0.59 USD in Q4'23, EPS rebounded to a peak of 0.78 USD in Q3'24 before declining again. The YoY growth rate also fluctuated widely, highlighted by a dramatic 50% surge in Q2'25 and steep declines in several quarters, underscoring ongoing instability in the company's earnings trajectory during this timeframe.